BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.20, $0.10 better than the analyst estimate of $0.10. Revenue for the quarter came in at $48.6 million versus the consensus estimate of $46.54 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.